Moreover, whilst the immunosuppressive effect of the CD200/CD200R signaling pathway seems to be somewhat inhibited in patients with PAH, the effective CD200/CD200R signaling pathway may actually counterbalance the effect of cytokine secretion. This evidence concerns the gene CD200R1 and pulmonary arterial hypertension.